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1. INTRODUCTION {#jcp26362-sec-0002}
===============

Choriocarcinoma (CC) is one of the gestational trophoblastic neoplasias (GTNs), which is characterized by human chorionic gonadotropin (hCG) elevation as a malignant lesion often arising in childbearing years women (Lurain, [2011](#jcp26362-bib-0020){ref-type="ref"}). The overall cure rate in the CC is currently about 80%, which is the result of the inherent sensitivity to chemotherapy (Seckl et al., [2013](#jcp26362-bib-0024){ref-type="ref"}). However, parts of these develop drug resistance in the chemotherapy, which result in reduction of therapeutic effect, leading to metastatic lesion or adding risk of hysterectomy, and loss of fertility (Chen et al., [2007](#jcp26362-bib-0001){ref-type="ref"}). It is important to investigate the mechanism responsible for resistance and discover new drugs reversing drug resistance.

One model that has received considerable attention in last years relates with the acquisition of resistance to chemotherapy by suppressed‐apoptosis (Rathore, McCallum, Varghese, Florea, & Büsselberg, [2017](#jcp26362-bib-0023){ref-type="ref"}). Importantly the high level of apoptosis was observed in methotrexate‐resistant JEG‐3 cells compared with parental cells (Shen et al., [2015](#jcp26362-bib-0026){ref-type="ref"}). Indeed, we also found that there were different levels of apoptosis variation in drug‐resistant CC cells in preliminary experiment. Hence, we hypothesized that apoptosis inhibition may contribute to the development of drug resistance.

NFIL3 (nuclear factor interleukin 3 regulated, also known as E4 binding protein 4, E4BP4) impacts many cellular processes and is widely expressed in human tissues, especially could highly induced by hCG treatment (Kashiwada, Pham, Pewe, Harty, & Rothman, [2011](#jcp26362-bib-0013){ref-type="ref"}; Li, Liu, & Jo, [2011](#jcp26362-bib-0014){ref-type="ref"}). Apoptosis plays a major role in development and tissue homeostasis (Fuchs & Steller, [2011](#jcp26362-bib-0006){ref-type="ref"}; Lim, Yang, Bazer, & Song, [2017](#jcp26362-bib-0016){ref-type="ref"}). NFIL3 could inhibits apoptosis in numerous settings from B‐cells to motor neurons, which 50% undergo apoptosis (Ikushima et al., [1997](#jcp26362-bib-0012){ref-type="ref"}). High‐expression of NFIL3 in embryonic rat and chicken motor neurons that survive developmental pruning, while more than half of the motor neurons produced undergo programmed cell death (Raff et al., [1993](#jcp26362-bib-0022){ref-type="ref"}). In line with its ability to hinder cell death, NFIL3 has emerged as a novel survival factor in cancer. In the research of mechanisms in IL‐10‐mediared anti‐inflammatory effect, it is found that NFIL3 is a key component of the STAT3‐mediated anti‐inflammatory mechanism (Smith et al., [2011](#jcp26362-bib-0027){ref-type="ref"}). Signal transducer and activator of transcription 3 (STAT3) belongs to STAT family of proteins. Constitutively active STAT3 mediates critical gene expression changes and molecular events that regulating cell growth and apoptosis (Turkson & Jove, [2000](#jcp26362-bib-0031){ref-type="ref"}; Yang et al., [2012](#jcp26362-bib-0034){ref-type="ref"}). As a now validated anticancer drug target, the inhibitors of the STAT3 pathway as a novel approach to inducing cancer cell apoptosis and hence treating cancer patients (Niu et al., [2011](#jcp26362-bib-0021){ref-type="ref"}; Zhang, Zhou, Gu, Yan, & Zhang, [2014](#jcp26362-bib-0036){ref-type="ref"}). But the clinical safety of these compound is not clear, investigation of new usage in traditional drugs is more popular.

Several traditional Chinese medicines are used for the treatment of tumors including gynecological carcinomas in China. Raddeanin A (RA) is an oleanane‐type triterpenoid saponin extracted from the root of *Anemone raddeana* Regelm, a traditional Chinese medicinal herb (Luan et al., [2013](#jcp26362-bib-0019){ref-type="ref"}). The mainly functions of RA which once reported are developed to anti‐inflammation and anti‐tumor treatments (Guan et al., [2015](#jcp26362-bib-0009){ref-type="ref"}). Previous studies have also shown that RA induced apoptosis and inhibited invasion in human gastric cancer cells (Xue et al., [2013](#jcp26362-bib-0033){ref-type="ref"}). And in our preliminary studies, RA can suppress choriocarcinoma JEG‐3 cells proliferation (unpublished data). More importantly, RA showed synergy with cisplatin in therapeutic effect in human hepatocellular carcinoma (Li et al., [2017](#jcp26362-bib-0015){ref-type="ref"}). However, its effect and mechanisms on drug resistance are still largely unknown. In this study, the possible mechanisms of resistance, and the inhibitory effects of RA on the reversal resistance of chemotherapeutics in CC were investigated.

2. MATERIALS AND METHODS {#jcp26362-sec-0003}
========================

2.1. Drug and cells {#jcp26362-sec-0004}
-------------------

Raddeanin A was obtained from National Institute for the Control of Pharmaceutical and Biological Products (Beijing, CN). The human choriocarcinoma JEG‐3 cell line was laboratory‐preserved which purchased from the American Type Culture Collection (ATCC, Manassas, VA) (Shi, Tan, Lu, Yang, & Zhang, [2014](#jcp26362-bib-0002){ref-type="ref"}). Anti‐etoposide cell line named JEG‐3/VP16 was purchased from the China Center for Type Culture Collection (Wuhan, China). Cells were cultured in DMEM‐high glucose supplemented (Gibco, Rockford, IL) with 10% FBS (Gibco), 50 U/ml penicillin, and 50 µg/ml of streptomycin at 37 °C in a 5% CO~2~ atmosphere.

2.2. Establishment of drug‐resistant sublines {#jcp26362-sec-0005}
---------------------------------------------

Methotrexate (MTX)‐ and fluorouracil (5‐FU)‐resistant variants were obtained by exposing parental cell line to stepwise increased MTX and 5‐FU (Sigma, St. Louis, MO) concentrations by intermittent‐ and consecutive‐feeding methods (Snow & Judd, [1991](#jcp26362-bib-0028){ref-type="ref"}). The JEG‐3/MTX obtained by initially exposing JEG‐3 from 0.001 to 10 µg/ml MTX until they achieved a growth rate like untreated cells. The JEG‐3/5‐FU was the same, whereas they exposed in the 5‐FU concentration from 0.025 to 50 µg/ml.

2.3. Cell proliferation assay {#jcp26362-sec-0006}
-----------------------------

The inhibitory concentration 50% (IC~50~) was explored with Cell Counting Kit‐8 (Dojindo, Kumamoto, JPN) assay as per the protocols. Total of 2 × 10^4^ all four kinds of cells were seeded into 96‐well plates with approximately 80% cellular fusion. Then cells were treated with drugs for 48 hr, each well was added 10 μl CCK‐8 for 2 hr at 37 °C. The absorbance was measured at 450 nm with a microplate reader (BioTek, Winooski, VT). Resistance Index (RI) = IC~50~ of the drug‐resistant cells/IC~50~ of the parent cells.

2.4. Flow cytometric analysis for apoptosis {#jcp26362-sec-0007}
-------------------------------------------

To analyze cell apoptosis, cells with varies treatments were stained by propidium iodide (PI) and FITC‐Annexin V as the Apoptosis Detection Kit (BD, Franklin Lakes, NJ) protocol, tested by Flow Cytometer (BD). The results analyzed by FlowJo software.

2.5. TUNEL assay {#jcp26362-sec-0008}
----------------

The cell TUNEL assay was performed using Apoptosis Detection Kit (Roche, Basel, CH) as the protocol. Briefly, Total 3 × 10^4^ cells were planted in six‐well plate with various treatments for 24 hr. The treated adherent cells were fixed in 4% paraformaldehyde for 15 min, then treated with TritonX‐100 for 15 min. Cells in every well were incubated with 50 μl TUNEL reaction solution (5 μl TdT +45 μl dUTP) in a humidified box at 37 °C for 1 hr. POD‐horseradish peroxidase incubated cells for 30 min, then colorized with DAB. The positive cells with green fluorescence was counted under a fluorescence microscope (Leica, Wetzlar, DE). Five high power microscopic views (×200) were chosen on each slide.

2.6. RNA extraction and real‐time polymerase chain reaction (RT‐PCR) {#jcp26362-sec-0009}
--------------------------------------------------------------------

Total RNA was extracted using the TRIzol reagent (Life Technologies, Rockford, IL) following the manufacturer\'s instruction. cDNA was reversely transcribed by a Transcriptor First Strand cDNA Synthesis Kit (Life Technologies). RT‐PCR was performed using SYBR PremixEx TaqTM II (Life Technologies) with ABI 7500 real‐time PCR system (Thermo, MMAS, Rockford, IL). The expression level was calculated with 2^−ΔΔCt^ versus control group. The primers sequences were listed in Supplementary Table S1.

2.7. Western blot analysis {#jcp26362-sec-0010}
--------------------------

Total proteins were extracted by RIPA lysis buffer (Beyotime biotechnology, Shanghai, CN) and quantified with the standard BCA method. Equivalent amounts of protein from each sample (30--50 µg) were loaded onto an SDS--PAGE gel and transferred onto PVDF membranes (Merck, Darmstadt, DE). TBST supplemented with 5% milk was used for blocking the membrane for 1 hr at room temperature, and then incubated with various primary antibodies (all the primary antibodies were purchased from CST, Darmstadt, DE; Phospho‐Stat3 (Tyr705)\#9415, STAT3\#9136, NFIL3\#14312, Cleaved Caspase‐3\#9664, Caspase‐3\#9662, Bcl‐2\#4223) at 4 °C overnight with gently shaking. Secondary antibodies (CST, Darmstadt, DE) were added for 1 hr and detected with ECL reagent (Millipore, Billerica, MA), and exposed by chemiluminescence system (Syngene, Cambridge, UK). The gray value of each band was measured by ImageJ software.

2.8. Transfection {#jcp26362-sec-0011}
-----------------

The scramble, NFIL3 siRNA (5′‐GAUGAGGGUGUAGUGGGCAAGUCUU‐3′) were synthesized by Ribobio (Guangzhou, CN). Cells were seeded in six‐well plates with a density of 2 × 10^5^ cells/well and transfected with siRNAs using the riboFECT™ CP (Ribobio, Guangzhou, CN). The LV‐STAT3‐RNAi was provided by Open Biosystems (RMM3981‐97059843, clone ID TRCN0000071456). The over‐expression Lenti‐OE™‐STAT3 and Lenti‐OE™‐NFIL3 were provided by Genechem (Shanghai, CN), which transfected into cells for 48 hr.

2.9. Luciferase reporter assay {#jcp26362-sec-0012}
------------------------------

The NFIL3 promoter including the wild STAT3‐NFIL3 binding sites or mutant type was cloned into the pGL3‐Basic vector (Ribobio, Guangzhou, China). The luciferase reporter assay (Promega, Madison, WI) executed following the luciferase reporter assay protocol. JEG‐3 cells were co‐transfected with reporter plasmid (pGL3‐NFIL3 wt/mt), STAT3, shSTAT3, or treated with 50 ng/ml IL‐6 (Sigma) treatment as indicated. The fluorescence value was detected by GloMax‐multimode reader (Promega).

2.10. Co‐immunoprecipitation {#jcp26362-sec-0013}
----------------------------

The total protein was lysed in RIPA lysis buffer, and then was incubated with anti‐pSTAT3 or IgG as a negative control. Added to agarose shaken for 4 hr at 4 °C and centrifuged for 5 min at 2,500*g* following. The washed precipitation was suspended in SDS buffer with primary antibodies against p‐STAT3 and NFIL3, used for Western blot analyses.

2.11. Bioinformatic data mining {#jcp26362-sec-0014}
-------------------------------

We downloaded GEO data of different resistant cells from GEO DataSedts (<https://www.ncbi.nlm.nih.gov/gds/>) as our samples of correlation analysis. The molecular functional network map of canonical pathways including co‐expression, co‐lacalization, genetic interactions, pathway, physical interactions, predicted networks of NFIL3 analyzed by GeneMANIA (<http://genemania.org/>).

2.12. Statistical analysis {#jcp26362-sec-0015}
--------------------------

Statistical analysis was performed using SPSS 17.0 software. The datas expressed as the mean ± standard deviation. One‐way ANOVA test was used to examine the statistical difference of datas between the groups. Spearman correlation analysis was used to test the co‐expression correlation of STAT3 and NFIL3. The significance was defined as *p*‐values \<0.05.

3. RESULT {#jcp26362-sec-0016}
=========

3.1. Low rate of apoptosis in drug‐resistant cells {#jcp26362-sec-0017}
--------------------------------------------------

To identify factors that contribute to the development of chemotherapeutics‐resistance in CC cells, besides the JEG‐3/VP16, we performed serial culturing to establish other two resistant sublines of JEG‐3 cells, which was named JEG‐3/MTX and JEG‐3/5‐FU. After almost 10 months drug induction, we got resistant cells as Figure [1](#jcp26362-fig-0001){ref-type="fig"}a shows. CCK‐8 assay used in investigating the chemosensitivity. As representatively demonstrated in Figure [1](#jcp26362-fig-0001){ref-type="fig"}b, the resistant cells all showed higher IC~50~ against JEG‐3 cells. Exposing the methotrexate, the JEG‐3/MTX cells exhibited a mean IC~50~ of 32.53 µg/ml while the JEG‐3 cells exhibited a mean IC~50~ = 1.156 µg/ml (*p *\< 0.01). In JEG‐3/5‐FU cells, the JEG‐3/5‐FU cells exhibited a mean IC~50~ of 196.530 µg/ml while the JEG‐3 cells exhibited a mean IC~50~ = 6.418 µg/ml (*p *\< 0.01). Finally, in JEG‐3/VP16 cells exhibited a mean IC~50~ = 73.079 µg/ml while the JEG‐3 cells exhibited a mean IC~50~ = 2.448 µg/ml (*p *\< 0.001). Consistently, the resistant cells showed more than 20‐fold resistance against parent cells. After repeated experiments, we found that the three sublines showed a low rate of apoptosis exposing chemotherapeutics using Flow cytometry (Figure [1](#jcp26362-fig-0001){ref-type="fig"}c) and TUNEL (Figure [1](#jcp26362-fig-0001){ref-type="fig"}d) assay detecting. Then, the apoptins changed in the chemotherapeutic‐induced apoptosis were observed (Figure [1](#jcp26362-fig-0001){ref-type="fig"}e). Whether the parent cells or derivate cells, the caspase 3 pathway was activated similarly. The anti‐apoptosis protein Bcl‐2 level was increased reversely.

![Low rate of apoptosis in drug‐resistant cells. (a) The cell morphology of four cells, scale bars 200 µm. (b) IC~50~ dose response curves of methotrexate, fluorouracil, and etoposide in three sublines versus JEG‐3 cells. (c) Representative flow cytometry images of annexin V/PI‐stained four cell lines treated with drugs for 24 hr. (d) Representative images of TUNEL‐stained cells treated with chemotherapeutics for 24 hr, blue DAPI‐stained nuclei, green TUNEL‐stained positive nuclei, scale bars 100 µm (left). Respective TUNEL‐positive cells are depicted as percent (right). (e) Cleaved‐Caspase 3, Caspase 3 and Bcl‐2 protein level in cells treated with chemotherapeutics for 24 hr. GAPDH was used as the internal control (above). Respective changes in protein levels are depicted as fold change (under). Data represent mean ± SD from at least three independent experiments, \*\*\**p *\< 0.001](JCP-233-5370-g002){#jcp26362-fig-0001}

3.2. NFIL3 represses drug‐induced apoptosis {#jcp26362-sec-0018}
-------------------------------------------

In the procession of establishment of drug‐resistant cells, NFIL3 protein level highly increased as cultivating generation (Figure [2](#jcp26362-fig-0002){ref-type="fig"}a) with chemotherapeutics. We hypothesized that NFIL3 related to the formation of drug resistance. To test it, cells transfected with NFIL3 siRNA was established. As the Figure [2](#jcp26362-fig-0002){ref-type="fig"}b showed, the IC~50~ of chemotherapeutics was significantly decreased in the siNFIL3 group compared with controls (mock group; *p *\< 0.001). To study whether NFIL3 repressed chemotherapeutics‐induced apoptosis in CC cells, TUNEL (Figure [2](#jcp26362-fig-0002){ref-type="fig"}c) and Flow cytometry (Figure [2](#jcp26362-fig-0002){ref-type="fig"}d) were used. The siNFIL3 group exposed in drugs for 24 hr, with a higher apoptosis rate than the NC‐treated cells (*p* \< 0.001).

![NFIL3 represses drug‐induced apoptosis. (a) Western blot analysis of NFIL3 protein levels in different generations of subline cells (left) and subsequent densitometric quantification (right; top to bottom are JEG‐3/MTX, JEG‐3/5‐FU, and JEG‐3/VP16). Changes in protein levels are represented as fold change comparison with JEG‐3 cells. (b) The IC~50~ dose response curves of Mock, NC‐treated, and siNFIL3‐treated in all subline cells tested in vitro. (c) Representative images of TUNEL‐stained cells treated with siNFIL3 or NC control, and then exposed to drugs for 24 hr. Blue DAPI‐stained nuclei, green TUNEL‐stained positive nuclei, scale bars 100 µm (above). Respective TUNEL‐positive cells are depicted as percent (under). (d) Cells were exposed to chemotherapeutics for 24 hr after Annexin V‐FITC/PI staining flow cytometry analysis was performed. Representative data are shown from three independent experiments. \*\**p *\< 0.01, \*\*\**p *\< 0.001](JCP-233-5370-g003){#jcp26362-fig-0002}

3.3. Activated STAT3 signaling enhances NFIL3 promoter activity {#jcp26362-sec-0019}
---------------------------------------------------------------

Aberrant IL‐6/STAT3 signaling in cancer cells have emerged as a major mechanism for cancer initiation and development. IL‐6 can induces STAT3 activation (Yu & Jove, [2004](#jcp26362-bib-0035){ref-type="ref"}), what is no exception in the drug‐resistant CC cells (Supplementary Figure S1). We performed a detailed analysis of the NFIL3 promoter in the NCBI database, and identified the main STAT3‐binding sites (Figure [3](#jcp26362-fig-0003){ref-type="fig"}a). Luciferase reporter vectors containing wild type and mutant type were constructed and subjected to luciferase reporter assay. The relative luciferase activity was significantly decreased with transfection of shSTAT3, but it was increased by STAT3 overexpression and IL‐6 stimulation (Figure [3](#jcp26362-fig-0003){ref-type="fig"}b). And the luciferase activity of reporter vector containing mutant type of STAT3‐binding site was unaltered by STAT3, shSTAT3, or IL‐6, suggesting that STAT3 enhances NFIL3 induced transcription activation via the site (Figure [3](#jcp26362-fig-0003){ref-type="fig"}c). Moreover, the stimulation of IL‐6 indeed enhanced only STAT3 in CC. Then, we examined whether STAT3 could form complexes with NFIL3 in drug‐resistant cells using co‐immunoprecipitation assay. As shown in Figure [3](#jcp26362-fig-0003){ref-type="fig"}d, activated STAT3 interacts with NFIL3 in three cell lines. Further, STAT3 RNAi decreased the level of NFIL3 expression and the overexpression STAT3 increased NFIL3 mRNA (Figure [3](#jcp26362-fig-0003){ref-type="fig"}e) and protein expression (Figure [4](#jcp26362-fig-0004){ref-type="fig"}e) level inversely.

![Activated STAT3 signaling enhances NFIL3 promoter activity. (a) Details of STAT3‐binding site in NFIL3 promoter. (b) Luciferase assays were performed in three cell lines transfected with STAT3, shSTAT3, or treated with IL‐6. (c) Luciferase assays were performed using mutant NFIL3 promoter. (d) Co‐immunoprecipitation assays showed that p‐STAT3 interacts with NFIL3 in three cell lines respectively. (e) NFIL3 mRNA expression was regulated in three cell lines transfected with shSTAT3 or STAT3 overexpression lentivirus. The results were presented as mean ± SD (*n* = 3). \**p *\< 0.05, \*\*\**p *\< 0.001](JCP-233-5370-g004){#jcp26362-fig-0003}

![Co‐expression of STAT3 and NFIL3 correlated with chemotherapy resistance. (a) Western blot analysis of STAT3 protein levels in different generations of subline cells (above) and subsequent densitometric quantification changes in protein levels are represented as fold change comparison with JEG‐3 cells (under). (b) The IC50 dose response curves of Mock, NC‐treated and siNFIL3‐treated in all subline cells tested in vitro. (c) Representative images of TUNEL‐stained cells treated with shSTAT3 or NC control, and then exposed to chemotherapeutics for 24 hr. Blue DAPI‐stained nuclei, green TUNEL‐stained positive nuclei, scale bars 100 µm (left). The Respective TUNEL‐positive cells are depicted as percent (right). (d) Cells were exposed to chemotherapeutics for 24 hr after Annexin V‐FITC/PI staining flow cytometry analysis was performed. (e) p‐STAT3, STAT3, NFIL3, Cleaved‐Caspase 3, Caspase 3, and Bcl‐2 protein levels in cells treated with chemotherapeutics for 24 hr. GAPDH was used as the internal control (above). Respective changes in protein levels are depicted as fold change (under). Representative data are shown from three independent experiments. \*\**p *\< 0.01, \*\*\**p *\< 0.001](JCP-233-5370-g005){#jcp26362-fig-0004}

3.4. Co‐expression of STAT3 and NFIL3 correlated with chemotherapy resistance {#jcp26362-sec-0020}
-----------------------------------------------------------------------------

As the same of NFIL3, STAT3 was activated as cultivating generation (Figure [4](#jcp26362-fig-0004){ref-type="fig"}a). We performed a rescue experiment in resistant cells by transfecting LV‐STAT3‐RNAi. As the Figure [4](#jcp26362-fig-0004){ref-type="fig"}b showed, the IC~50~ of chemotherapeutics was significantly decreased in the shSTAT3 transfected cells compared with controls (mock group; *p *\< 0.001). At the same time, LV‐STAT3‐RNAi increased the apoptotic rate subjected to chemotherapeutics which tested by TUNEL assay (Figure [4](#jcp26362-fig-0004){ref-type="fig"}c) and Flow cytometry analysis (Figure [4](#jcp26362-fig-0004){ref-type="fig"}d). Meanwhile, Caspase 3 dependent apoptosis pathway was activated by shSTAT3 (Figure [4](#jcp26362-fig-0004){ref-type="fig"}e). All above, activated STAT3 can affect the chemotherapeutic resistance by repressing apoptosis. The mechanism which STAT3 regulated during apoptosis is unknown. As the present study had confirmed STAT3 can regulate NFIL3 in CC cells, we hypothesized that STAT3 mediated apoptosis through regulating NFIL3 expression. As Figure [4](#jcp26362-fig-0004){ref-type="fig"}e Western blot showed, no matter shSTAT3 or siNFIL3 can increased cells apoptosis rate exposing drugs, but importantly the NFIL3 overexpression offset the apoptotic effect of shSTAT3. In addition, co‐transfection with shSTAT3 and siNFIL3 cells showed higher apoptosis stage.

Due to the less data of choriocarcinoma, we performed separately for methotrexate‐, fluorouracil‐ and etoposide‐resistant cells in different tumor using GEO DataSets. Results showed that the expression of STAT3 and NFIL3 were highly correlated whether in which one chemotherapeutic (Figure [5](#jcp26362-fig-0005){ref-type="fig"}a--c). To further observe the possible molecular pathway of NFIL3 and STAT3, the online GeneMANIA tool was used. The networks identified by GeneMANIA are shown in Figure [5](#jcp26362-fig-0005){ref-type="fig"}d. We observed some genes related with both STAT3 and NFIL3 directly, listed in Supplementary Table S2. Together these results indicate the co‐expression of STAT3 and NFIL3 correlate with chemotherapy resistance.

![NFIL3 expression positively correlates with the levels of STAT3. (a) NFIL3 and STAT3 mRNA expression levels in methotrexate‐resistant cells versus parent cells. (a1) for choriocarcinoma JEG‐3 cells in GSE88873; (a2) for colon cancer HT29 cells in GSE16648; (a3) for osteosarcoma Saos‐2 cells in GSE16648. (b) NFIL3 and STAT3 mRNA expression levels in fluorouracil‐resistant cells versus parent cells. (b1) for colon cancer HCT116 cells in GSE56322; (b2) for esophageal cancer TE‐5 cells in GSE69494. (c) NFIL3 and STAT3 mRNA expression levels in etoposide‐resistant cells versus parent cells. (c1) for breast cancer MCF‐7 cells in GSE28415; (c2) for malignant melanoma MeWo cells in GSE78898. (d) The molecular functional network map of NFIL3 and STAT3 analyzed by GeneMANIA tool](JCP-233-5370-g006){#jcp26362-fig-0005}

3.5. Raddeanin A induced apoptosis to reverse drug resistance {#jcp26362-sec-0021}
-------------------------------------------------------------

The chemical structure of RA showed as Figure [6](#jcp26362-fig-0006){ref-type="fig"}a. Given the drug‐resistant cells showed a low rate of apoptosis which related with drug tolerance, to further confirm RA\'s induction of cell apoptosis, western blot was applied to analyze the apoptosis‐related molecules. Cells were treated by three different dosages RA for 24 hr and the results showed that the Cleaved‐Caspase 3, Bcl‐2 levels changed significantly in a dose‐dependent manner (Figure [6](#jcp26362-fig-0006){ref-type="fig"}b). Cells was treated with the maximal dose 8 µM RA we used for 24 hr beforehand, and then exposing to methotrexate, fluorouracil or etoposide before analyzed by TUNEL assay (Figure [6](#jcp26362-fig-0006){ref-type="fig"}c) and flow cytometric (Figure [6](#jcp26362-fig-0006){ref-type="fig"}d). The apoptosis rate increased from 6.32% to 53% (JEG‐3/MTX, *p *\< 0.001), from 2.25% to 56.1% (JEG‐3/5‐FU, *p *\< 0.001), and from 7.51% to 47.2% (JEG‐3/VP16, *p *\< 0.001) respectively. The IC~50~ value of resistant cells exposing to chemotherapeutics were decreased with RA dose added (Figure [6](#jcp26362-fig-0006){ref-type="fig"}e, *p *\< 0.05). To further confirmed that RA reversed drug resistance through inducing apoptosis, apoptotic inhibitor Z‐VAD‐FMK (Selleck, Shanghai, China) was used (Liu et al., [2015](#jcp26362-bib-0018){ref-type="ref"}). The IC~50~ value increased apparently which cells treated with 8 µM RA and 50 µM Z‐VAD‐FMK together against DSMO group (Figure [6](#jcp26362-fig-0006){ref-type="fig"}f, *p* \< 0.01).

![Raddeanin A induced apoptosis to reverse drug resistance. (a) Chemical structure of RA. (b) Cells were treated with RA for 24 hr, and total proteins were extracted. Cleaved‐Caspase 3, Caspase 3, and Bcl‐2 protein levels analyzed by Western blot. Equal protein loading was evaluated by GAPDH (left). Respective changes in protein levels are depicted as fold change (under). (c) Representative images of TUNEL‐stained cells treated with 8 µm RA or not for 24 hr, and then exposed to drugs. Blue DAPI‐stained nuclei, green TUNEL‐stained positive nuclei, scale bars 100 µm (left). The Respective TUNEL‐positive cells are depicted as percent (right). (d) Cells were exposed to chemotherapeutics for 24 hr after Annexin V‐FITC/PI staining flow cytometry analysis was performed. (e) IC~50~ dose response curves of cells with different doses RA in three sublines. (f) Cells were treated with 8 µm RA for 24 hr, IC~50~ dose response curves of cells with 50 µm Z‐VAD‐FMK in three sublines versus DMSO group. Data represent mean ± SD from at least three independent experiments, \**p *\< 0.05, \*\**p *\< 0.01, \*\*\**p *\< 0.001](JCP-233-5370-g007){#jcp26362-fig-0006}

3.6. Raddeanin A‐induced apoptosis was STAT3/NFIL3‐dependent {#jcp26362-sec-0022}
------------------------------------------------------------

To explore the molecular mechanisms underlying RA‐mediated apoptosis, we tested if RA can regulate the STAT3/NFIL3 pathway in drug‐resistant cells. RA significantly suppressed STAT3 activation and NFIL3 protein expression in each cell lines with dose‐dependent manner. But the phenomenon was reversed by STAT3 activator IL‐6, suggesting that STAT3/NFIL3 pathway may be involved in RA‐mediated apoptosis (Figure [7](#jcp26362-fig-0007){ref-type="fig"}a). Very obviously, the Caspase 3 inactivated and Bcl‐2 expression increased (Figure [7](#jcp26362-fig-0007){ref-type="fig"}b). Flow cytometry (Figure [7](#jcp26362-fig-0007){ref-type="fig"}c, *p *\< 0.001) and TUNEL (Figure [7](#jcp26362-fig-0007){ref-type="fig"}d) demonstrated the STAT3 stimulating factor IL‐6 abrogated the RA‐mediated apoptosis. All these above indicate that the STAT3/NFIL3 axis play a crucial role in RA‐inducing apoptosis resisting chemoresistance.

![Raddeanin A‐induced apoptosis was STAT3/NFIL3‐dependent. (a) Cells were treated with RA for 24 hr, and total proteins were extracted. p‐STAT3, STAT3, and NFIL3 protein levels analyzed by Western blot. Equal protein loading was evaluated by GAPDH (above). Respective changes in protein levels are depicted as fold change (under). (b) Protein expression levels were analyzed in three cells after 8 µm RA with IL‐6 (100 ng/ml) treatment or not for 24 hr using Western blots. (c) Cell apoptosis was measured using the flow cytometry 24 hr post RA with IL‐6 treatment or not. (d) Representative images of TUNEL‐stained cells treated with RA and IL‐6 or not for 24 hr, and then exposed to corresponding drugs. Blue DAPI‐stained nuclei, green TUNEL‐stained positive nuclei, scale bars 100 µm. Data represent mean ± SD from at least three independent experiments, \**p* \< 0.05, \*\*\**p* \< 0.001](JCP-233-5370-g008){#jcp26362-fig-0007}

4. DISCUSSION {#jcp26362-sec-0023}
=============

Preventing and reversing chemoresistance of choriocarcinoma have become one of the focuses of the present studies (Horowitz, Goldstein, & Berkowitz, [2017](#jcp26362-bib-0010){ref-type="ref"}). For the low‐risk choriocarcinoma, methotrexate and fluorouracil are the first‐line chemotherapy drugs in choriocarcinoma as monotherapy regimen, and liable to cause resistance. As the most vital regimen for high‐risk, relapsing, and resistant choriocarcinoma, EMA‐CO regimen involves etoposide which occurs multidrug resistance reported before (Shen et al., [2015](#jcp26362-bib-0026){ref-type="ref"}). In current study, the JEG‐3/MTX, JEG‐3/5‐FU, and JEG‐3/VP16 were used for resistance models. Caspase‐cascade is a central part of cell apoptosis and regulated by various kinds of molecules, such as Bcl‐2 family proteins (Fan, Han, Cong, & Liang, [2005](#jcp26362-bib-0003){ref-type="ref"}; Ghavami et al., [2009](#jcp26362-bib-0007){ref-type="ref"}). Evidence suggests that some high dosage chemotherapy leads to caspase‐independent cell death, but it remains unclear if toxicity to health cells may be a compromising factor in its effectiveness (Su, Yang, Xie, DeWitt, & Chen, [2016](#jcp26362-bib-0029){ref-type="ref"}). CC cells exhibit intrinsic resistance to chemotherapy drugs, often attributed to high endogenous expression of drug efflux transporters such as MDR1 and some acquired chemoresistance in them develop generations (Ikeda et al., [2012](#jcp26362-bib-0011){ref-type="ref"}). To combat both intrinsic and acquired chemoresistance, and thus prevent the eventual invincibility of cancer cells, it is important to solve the apoptosis‐mediated chemoresistance. We observed the drug‐resistant cells showed a low rate of apoptosis contrast to JEG‐3 cells. Further the Caspase 3 were activated by chemotherapeutics, including Bcl‐2 suppression, which indicated the cell apoptosis pathway. These results hinted us to stat with apoptosis issue for solving chemotherapy resistance.

As the survival factor, over‐expression of NFIL3 in rat embryonic fibroblasts induced survival genes such as Bcl‐2 expression and hindered caspase 3 induction preventing apoptosis (Weng et al., [2010](#jcp26362-bib-0032){ref-type="ref"}), which was indeed supported by our current finding that NFIL3 expression increased following the cell generations and strikingly related with Caspase 3 dependent apoptosis. In addition, siNFIL3 influenced the IC~50~ value of the drug‐resistant cells, which indicated NFIL3‐inhibited apoptosis changed the chemoresistance. This is the first study to evaluate the correlation of NFIL3 and chemoresistance. And the most important what we found was a novel factor influencing choriocarcinoma resistance, which as the potential target for drugs. However, there is no special inhibitor of NFIL3 and short of the direct‐bonding compounds.

On the other hand, fortunately, using NCBI database, we learned that the STAT3 possible bind to NFIL3 promoter. Several studies had suggested that IL6/STAT3 pathway was closely associated with the CC cells proliferation (Liu, Gu, & Li, [2013](#jcp26362-bib-0017){ref-type="ref"}). IL‐6 cytokine superfamily‐induced activation of STAT3 played a crucial role in induction of invasiveness of trophoblastic cells (Fitzgerald et al., [2005](#jcp26362-bib-0005){ref-type="ref"}). The expression of p‐STAT3 was confirmed related with chemotherapeutic resistance in ovarian, hepatocellular, and neck cancers (Gu et al., [2010](#jcp26362-bib-0008){ref-type="ref"}; Selvendiran et al., [2009](#jcp26362-bib-0025){ref-type="ref"}). The drug‐resistant JEG‐3 cells demonstrated high level of pSTAT3/STAT3 protein expression, which also influenced apoptosis of CC. Besides the direct binding relationship was confirmed in the study, furthermore, down‐regulation of STAT3 promoted apoptosis through the suppression of NFIL3, and the activated Caspase 3 were detected. Our results further strengthened the results that anti‐ apoptotic effect of STAT3 over‐expression via regulating NFLI3, and the STAT3/NFIL3 pathway‐inhibited apoptosis resulted in chemotherapeutic resistance. But it is worth to mention that, in the observation of three different drug‐resistant cells, they showed slightly different results, which maybe there exist disparate resistance mechanism. JEG‐3/VP16 cells was detected MDR1 protein expression but JEG‐3/MTX and JEG‐3/5‐FU cells were not (Feng, Xiang, Cui, Liu, & Yang, [2003](#jcp26362-bib-0004){ref-type="ref"}). JEG‐3/MTX showed endoplasmic reticulum stress which induced apoptosis including caspase 9 pathway (Shen et al., [2015](#jcp26362-bib-0026){ref-type="ref"}). Although further studies are necessary to address the unique resistance mechanism of each resistant cell line, our data allude to a possible mechanism by which STAT3/NFIL3 signaling axis may protect all kinds of drug‐resistant cells from apoptosis of chemotherapy drugs.

It is short of big data of choriocarcinoma due to the difficulty in obtaining tissue samples. We analyzed the correlation of STAT3 and NFIL3 in different drug‐resistant cells, including colon cancer, breast cancer, malignant melanoma etc. via GEO data. Despite the small sample sizes, the results all indicate the positive correlation of them, further verify our present study. In the predict molecular pathways, we found some interesting molecule related with both STAT3 and NFIL3 directly, such as CREB1 (cAMP responsive element binding protein 1) and NFKBIZ (NFKB inhibitor zeta), which hint that more research can be performed to investigate the regulatory network of STAT3/NFIL3 axis.

Fighting apoptosis is the principal mechanism of tumor cell to resisting death and is an important pointcut for the development of anticancer drugs. In human GC cells, RA can regulate the Bcl‐2 family to induce apoptosis (Teng et al., [2016](#jcp26362-bib-0030){ref-type="ref"}). However, the research on CC cells is still blank. In the present study of CC cells, RA induced apoptosis on both early and late stages via Caspase 3 dependent apoptosis. More importantly, RA reversed the resistance index of resistant cells effectively in dose‐dependent manner, which counteracted by Z‐VAD‐FMAK. Our data now further validate and expand upon the previous findings and provide novel insights into the RA‐induced apoptosis controlling the reversal of chemotherapeutic resistance including methotrexate, fluorouracil, and etoposide. Unlike other complementary medicines, RA is more stable in aqueous solution and is less toxic. Low‐dose RA used in present study showed effective effect against traditional chemotherapy drugs. Further, we sought to focus our investigation on mechanism in reversal resistance of RA. We observed that RA could repress STAT3 activation and down‐regulate NFIL3 expression which mediated by IL‐6/STAT3 signaling axis. More importantly, in this study, activated p‐STAT3 and NFIL3 could weaken the apoptotic effect of RA, indicating that the activated STAT3/NFIL3 signaling axis results in the changes: loss of apoptosis and chemotherapeutic resistance.

In conclusion, our data support the hypothesis that STAT3/NFIL3 signaling axis‐repressed apoptosis is a dominating driving factor responsible for chemotherapeutic resistance, which could be reversed by RA.
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**Fig. S1**. IL‐6 activated STAT3 in resistant cells.
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